Arrowhead Pharmaceuticals, Inc. (ARWR) has a consensus analyst rating of Buy, based on 20 analysts covering the stock. Of those, 14 recommend buying, 6 recommend holding, and 0 recommend selling.
The analyst consensus price target for ARWR is $78.78, representing a +18.1% upside from the current price of $66.69. Price targets range from a low of $35.00 to a high of $110.00.
